08048035968
Cladrim 10 mg Injection UK Wholesale – Manchester |Competitive Prices |Phoenix Exim|Trusted Exporter

1. General Information

Cladrim 10 mg Injection is an anticancer prescription medicine containing cladribine 10 mg. Cladribine is a purine nucleoside analogue that interferes with the growth and survival of certain abnormal blood cells. The medicine is primarily indicated for hairy cell leukemia (HCL) and is administered by intravenous infusion under medical supervision.

Cladrim is a prescription-only medicine and should be used only according to the treatment plan established by an oncologist or other qualified healthcare professional.

Exporter: Phoenix Exim
Location: Nagpur, India
Export markets: USA, UK, Australia, Singapore, Canada, South Korea and UAE

2. Product Information

  • Brand: Cladrim
  • Strength: 10 mg
  • Active ingredient: Cladribine
  • Dosage form: Injection
  • Therapeutic category: Antineoplastic / anticancer medicine
  • Drug class: Purine analogue / antimetabolite
  • Route: Intravenous infusion
  • Prescription status: Prescription medicine
  • Storage: Follow the manufacturer's packaging and storage instructions; one Indian product listing specifies storage below 30°C.

Cladribine injection products are also available as 10 mg in 10 mL (1 mg/mL) presentations in the U.S.

3. Uses of Cladrim 10 mg Injection

Cladrim 10 mg Injection is primarily used for:

  • Hairy cell leukemia (HCL)
  • Treatment of abnormal cancerous blood cells associated with this condition

Hairy cell leukemia is a rare blood and bone-marrow cancer involving abnormal B lymphocytes. Cladribine is used to destroy or suppress these abnormal cells.

The medicine may be used in other clinical situations only when specifically determined appropriate by a specialist.

4. Benefits of Cladrim 10 mg Injection

The principal therapeutic benefit of cladribine is its ability to reduce or eliminate abnormal leukemia cells.

Potential benefits include:

  • Helps control hairy cell leukemia.
  • Targets abnormal lymphoid cells.
  • Interferes with the multiplication of cancer cells.
  • Can produce significant reduction of malignant cells when used appropriately.
  • May help improve blood-cell counts and disease-related symptoms following successful treatment.

The expected response and duration of benefit vary between patients and should be assessed through clinical examination and laboratory testing.

5. Side Effects of Cladrim 10 mg Injection

Because Cladrim is an anticancer medicine, it can affect both abnormal and normal blood-forming cells.

Possible adverse effects include:

  • Reduction in white blood cells
  • Reduction in red blood cells
  • Reduction in platelets
  • Fever
  • Infection
  • Nausea
  • Fatigue or weakness
  • Headache
  • Rash
  • Injection-site reactions

Bone-marrow suppression is an important safety concern with cladribine and requires appropriate monitoring.

Seek urgent medical attention for signs of serious infection, unusual bleeding or bruising, severe weakness, or neurological symptoms.

6. Common Side Effects

Reported or commonly described side effects may include:

  • Nausea
  • Fatigue
  • Headache
  • Rash
  • Fever
  • Weakness
  • Vomiting
  • Abdominal discomfort
  • Constipation
  • Dizziness
  • Injection-site discomfort

Not every patient experiences these effects. Some side effects may require medical evaluation, particularly when associated with low blood-cell counts or infection.

7. How to Use Cladrim 10 mg Injection

Cladrim 10 mg Injection must not be self-administered.

It is given by a doctor or trained healthcare professional, generally through an intravenous route. The exact dose, infusion schedule and duration depend on the patient's condition, blood counts, kidney function and the treating specialist's protocol.

Patients should:

  1. Receive the medicine only under qualified medical supervision.
  2. Follow the prescribed treatment schedule exactly.
  3. Complete recommended blood tests and medical monitoring.
  4. Inform the healthcare team about all medicines and supplements being taken.
  5. Report fever, chills, unusual bleeding or other concerning symptoms promptly.

The exact administration regimen should always be taken from the prescribing physician and the applicable product label rather than from a general product description.

8. How Cladrim 10 mg Injection Works

Cladribine is a purine nucleoside analogue. After entering susceptible cells, it is converted into active metabolites that interfere with DNA synthesis and repair.

This damages the DNA of susceptible abnormal lymphocytes and can prevent them from growing and multiplying, ultimately leading to their destruction.

This mechanism makes cladribine particularly useful against certain abnormal lymphoid cells involved in hairy cell leukemia.

9. Safety Advice for Cladrim 10 mg Injection

Prescription use

Use only under the supervision of an oncologist or qualified healthcare professional. The U.S. labeling specifically states that cladribine injection should be administered under supervision of a physician experienced with antineoplastic therapy.

Blood counts

Cladribine can suppress bone-marrow function. Regular blood tests are important to monitor white cells, red cells and platelets.

Infection

Because treatment can reduce immune-cell counts, patients may become more susceptible to infections. Report fever, chills, sore throat or other signs of infection promptly.

Pregnancy

Cladribine can pose a risk to a developing fetus. Pregnancy should be discussed with the treating physician before treatment.

Breastfeeding

Breastfeeding should be discussed with the treating healthcare professional because cladribine may pose risks to an infant.

Kidney and liver conditions

Inform the doctor about kidney or liver disease before treatment. Appropriate clinical assessment and monitoring may be required.

Drug interactions

Tell the healthcare professional about all prescription medicines, over-the-counter medicines, vitamins and supplements before receiving treatment.

Neurological symptoms

High-dose cladribine exposure has been associated with serious neurological toxicity. The official labeling warns about this risk, particularly with substantially higher-than-recommended doses.

10. Frequently Asked Questions (FAQs)

Q1. What is Cladrim 10 mg Injection used for?
Cladrim contains cladribine and is primarily used for treating hairy cell leukemia.

Q2. Is Cladrim 10 mg an anticancer medicine?
Yes. Cladribine is an antineoplastic medicine used against certain blood cancers.

Q3. How is Cladrim 10 mg administered?
It is administered intravenously by qualified healthcare professionals. It should not be self-injected.

Q4. Can Cladrim be taken without a prescription?
No. It is a prescription anticancer medicine and requires specialist supervision.

Q5. Does Cladrim affect blood counts?
Yes. Bone-marrow suppression and reductions in blood-cell counts can occur, so regular blood monitoring is important.

Q6. Can Cladrim cause infection?
It can increase infection risk because it may reduce certain blood cells. Patients should promptly report signs of infection.

Q7. Can Cladrim be used during pregnancy?
Pregnancy-related risks should be discussed with the treating physician. Cladribine can be harmful to a developing fetus.

Q8. Does Cladrim cause hair loss?
Available Indian product information states that hair loss is not a typical effect, although another pharmacy source reports it as an uncommon possible effect. Patients should discuss any unexpected hair loss with their doctor.

Q9. How should Cladrim be stored?
Follow the manufacturer's storage instructions on the product packaging. One Indian listing specifies storage below 30°C.

Q10. Who should administer Cladrim?
A qualified healthcare professional experienced in administering anticancer medicines should administer it.

11. Substitute for Cladrim 10 mg Injection

Substitution should be based on the same active ingredient, strength, dosage form and applicable regulatory approval, and should only be made by a qualified healthcare professional.

Possible cladribine injection alternatives may include products labelled as:

  • Cladribine Injection 10 mg
  • Cladribine Injection USP 10 mg/10 mL
  • Other approved cladribine 10 mg injection products

U.S. labeling confirms cladribine injection presentations containing 10 mg in 10 mL (1 mg/mL).

Do not replace Cladrim with another anticancer medicine merely because it is used for the same cancer. Any therapeutic substitution must be decided by the treating oncologist.

12. SEO & B2B Keywords

Product Keywords

  • Cladrim 10 mg Injection
  • Cladrim 10mg Injection
  • Cladribine 10 mg Injection
  • Cladribine Injection supplier
  • Cladribine 10mg Injection exporter
  • Cladribine injection manufacturer India
  • Cladrim 10 mg pharmaceutical supplier
  • Cladribine anticancer injection
  • Cladribine hairy cell leukemia treatment
  • Cladribine oncology medicine supplier

Long-Tail B2B Keywords

  • Cladrim 10 mg Injection exporter from India
  • Cladribine 10 mg Injection supplier from Nagpur India
  • Cladribine injection pharmaceutical exporter India
  • Cladrim 10 mg Injection wholesale supplier India
  • Cladribine 10 mg injection for international pharmaceutical supply
  • Cladrim 10 mg Injection bulk supplier
  • Cladribine oncology medicine exporter from India
  • Cladrim 10 mg Injection B2B pharmaceutical supplier
  • Cladribine Injection supplier for hospitals and distributors
  • Cladrim 10 mg Injection international pharmaceutical exporter

Country-Focused Keywords

  • Cladrim 10 mg Injection supplier USA
  • Cladrim 10 mg Injection exporter UK
  • Cladrim 10 mg Injection supplier Australia
  • Cladrim 10 mg Injection supplier Singapore
  • Cladrim 10 mg Injection exporter Canada
  • Cladrim 10 mg Injection supplier South Korea
  • Cladrim 10 mg Injection supplier UAE
  • Cladribine Injection exporter from India to USA
  • Cladribine Injection exporter from India to UK
  • Cladribine Injection exporter from India to Australia
  • Cladribine Injection exporter from India to Canada
  • Cladribine Injection exporter from India to UAE

Phoenix Exim SEO Keywords

  • Phoenix Exim Cladrim 10 mg Injection
  • Phoenix Exim Cladribine supplier India
  • Phoenix Exim oncology medicine exporter
  • Phoenix Exim pharmaceutical exporter Nagpur
  • Phoenix Exim anticancer medicine supplier
  • Cladrim 10 mg Injection from Phoenix Exim Nagpur
  • Cladribine medicine exporter from Nagpur India
  • trusted pharmaceutical exporter for Cladribine Injection
  • Indian pharmaceutical exporter for oncology medicines
  • Cladrim 10 mg international medicine supply from India
Aug 12th, 2026 4:03 PM

Keywords